J Alzheimers Dis 2025 (Jun 24): 13872877251351329

Figure 6.

Comparison of outpatient visits during the 3-year follow-up between propensity-score matched semaglutide and other antidiabetic medication groups in patients with T2D who had no prior diagnosis of AD/ADRD.